Crescent Biopharma, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to developing innovative protease therapeutics for hemostasis and complement regulation. The company boasts a promising pipeline targeting serious disorders related to blood coagulation and immune response, positioning it to meet critical unmet medical needs in these areas. Leveraging cutting-edge research methodologies and proprietary technologies, Crescent Biopharma is poised to deliver transformative treatments, establishing a significant presence in the dynamic biopharmaceutical sector. Show more

Location: 300 FIFTH AVENUE, WALTHAM, MA, UNITED STATES, 02451, Waltham, MA, 02451, USA | Website: https://crescentbiopharma.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

292.5M

52 Wk Range

$9.43 - $37.00

Previous Close

$10.14

Open

$10.20

Volume

198,439

Day Range

$9.43 - $11.21

Enterprise Value

181.4M

Cash

133.3M

Avg Qtr Burn

-6.269M

Insider Ownership

10.37%

Institutional Own.

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
CR-001 Details Solid tumor/s	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CR-003 (Topoisomerase Inhibitor ADC) Details Solid Tumors	IND Acceptance decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CR-002 (Topoisomerase Inhibitor ADC) Details Solid Tumors	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SQ Dalcinonacog alfa (DalcA) Details Hemophilia, Genetic disorder	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Marzeptacog alfa (MarzAA) Details Hemophilia, Blood disorder, Rare genetic disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.